X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2680) 2680
Publication (353) 353
Book Review (43) 43
Newsletter (41) 41
Newspaper Article (11) 11
Book Chapter (9) 9
Conference Proceeding (6) 6
Magazine Article (5) 5
Dissertation (2) 2
Book / eBook (1) 1
Data Set (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2057) 2057
index medicus (1488) 1488
glioblastoma (1229) 1229
animals (1014) 1014
oncology (983) 983
cancer (785) 785
angiogenesis (775) 775
brain neoplasms - pathology (765) 765
male (712) 712
female (706) 706
glioblastoma - pathology (693) 693
brain neoplasms - blood supply (677) 677
glioblastoma multiforme (655) 655
glioblastoma - blood supply (652) 652
tumors (575) 575
glioma (542) 542
gliomas (537) 537
mice (536) 536
cell line, tumor (498) 498
brain tumors (487) 487
middle aged (487) 487
clinical neurology (475) 475
adult (440) 440
glioblastoma - metabolism (417) 417
brain neoplasms - drug therapy (398) 398
brain neoplasms - metabolism (391) 391
aged (379) 379
glioblastoma - drug therapy (379) 379
expression (354) 354
chemotherapy (336) 336
endothelial growth-factor (324) 324
brain cancer (323) 323
glioma - pathology (318) 318
in-vivo (310) 310
glioblastoma-multiforme (308) 308
brain (307) 307
magnetic resonance imaging (287) 287
care and treatment (276) 276
cell biology (275) 275
brain-tumors (273) 273
mice, nude (271) 271
medicine & public health (269) 269
neurosciences (268) 268
research (265) 265
hypoxia (262) 262
glioma - blood supply (250) 250
growth (250) 250
analysis (249) 249
radiology, nuclear medicine & medical imaging (249) 249
vascular endothelial growth factor (241) 241
survival (231) 231
bevacizumab (228) 228
neovascularization, pathologic - pathology (227) 227
article (224) 224
rats (222) 222
radiotherapy (219) 219
immunohistochemistry (216) 216
surgery (216) 216
apoptosis (213) 213
glioblastoma - genetics (211) 211
neurology (205) 205
stem cells (205) 205
brain neoplasms - therapy (198) 198
neovascularization, pathologic - metabolism (197) 197
angiogenesis inhibitors - therapeutic use (195) 195
health aspects (193) 193
malignant glioma (193) 193
medicine (192) 192
pathology (190) 190
temozolomide (189) 189
brain neoplasms - genetics (188) 188
therapy (186) 186
proteins (181) 181
cell proliferation (177) 177
prognosis (176) 176
cells (173) 173
multidisciplinary sciences (173) 173
biochemistry & molecular biology (172) 172
glioma - drug therapy (170) 170
pharmacology & pharmacy (169) 169
development and progression (167) 167
gene expression (164) 164
neovascularization, pathologic (163) 163
neovascularization, pathologic - drug therapy (163) 163
invasion (161) 161
tumor cells, cultured (161) 161
malignant gliomas (159) 159
cancer therapies (156) 156
in-vitro (156) 156
glioma - metabolism (154) 154
research article (154) 154
metastasis (152) 152
central-nervous-system (151) 151
glioblastoma - therapy (150) 150
signal transduction (150) 150
vegf (148) 148
medicine, research & experimental (147) 147
xenograft model antitumor assays (142) 142
brain - blood supply (139) 139
brain neoplasms - diagnostic imaging (139) 139
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2695) 2695
French (16) 16
Japanese (14) 14
German (10) 10
Polish (4) 4
Chinese (3) 3
Hungarian (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 3/2011, Volume 108, Issue 9, pp. 3749 - 3754
Bevacizumab, an antibody against vascular endothelial growth factor (VEGF), is a promising, yet controversial, drug in human glioblastoma treatment (GBM). Its... 
Cellular metabolism | Glioma | Quantification | Perfusion | Glioblastoma | Blood vessels | Heterologous transplantation | Tumors | Cancer | Blood flow | Angiogenesis | Metabolism | TARGETED THERAPY | perfusion | angiogenesis | MULTIDISCIPLINARY SCIENCES | BEVACIZUMAB PLUS IRINOTECAN | BRAIN-TUMORS | ANTIANGIOGENIC THERAPY | PHASE-II TRIAL | STEM-LIKE CELLS | IN-VIVO | glioma | metabolism | RECURRENT MALIGNANT GLIOMAS | ENDOTHELIAL GROWTH-FACTOR | Glioblastoma - enzymology | Humans | Blood Volume - drug effects | Capillary Permeability - drug effects | Antibodies, Monoclonal - therapeutic use | Phosphatidylinositol 3-Kinases - metabolism | Vascular Endothelial Growth Factor A - metabolism | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Rats, Nude | Wnt Proteins - metabolism | Bevacizumab | Neovascularization, Pathologic - pathology | Antibodies, Monoclonal, Humanized | Glioblastoma - ultrastructure | Cell Hypoxia - drug effects | Neoplasm Invasiveness | Antibodies, Monoclonal - pharmacology | Rats | Enzyme Activation - drug effects | Disease Progression | Xenograft Model Antitumor Assays | Magnetic Resonance Imaging | Animals | Contrast Media | Signal Transduction - drug effects | Neovascularization, Pathologic - drug therapy | Glioblastoma - pathology | Glioblastoma - blood supply | Vascular endothelial growth factor | Health aspects | Glioblastoma multiforme | Biological Sciences | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Cancer and Oncology | Klinisk medicin | Cancer och onkologi
Journal Article
Proceedings of the National Academy of Sciences, USA, ISSN 0027-8424, 03/2011, Volume 108, Issue 9, pp. 3749 - 3754
Bevacizumab, an antibody against vascular endothelial growth factor (VEGF), is a promising, yet controversial, drug in human glioblastoma treatment (GBM). Its... 
Drugs | Brain | Alanine | Tumor cells | Hypoxia-inducible factor 1 alpha | Glioblastoma | Antibodies | Blood vessels | Bevacizumab | Signal transduction | Mitochondria | Magnetic resonance imaging | Metabolites | Glycolysis | Metabolic pathways | Lactic acid | spheroids | Vascular endothelial growth factor | Tumors
Journal Article
Journal Article
Journal of Experimental Medicine, ISSN 0022-1007, 08/2012, Volume 209, Issue 9, pp. 1611 - 1627
Journal Article
Neuroimage, ISSN 1053-8119, 2006, Volume 32, Issue 2, pp. 489 - 497
We utilized blood oxygenation level dependent (BOLD) functional magnetic resonance imaging (fMRI) and MR perfusion imaging methods to study the influence of... 
Prime Motor Cortex | Blood Oxygenation Level Dependent | Glioblastoma Multiforme | Relative Regional Cerebral Blood Volume | Functional Magnetic Resonance Imaging | LANGUAGE | PASSAGES | glioblastoma multiforme | PERMEABILITY | NEOPLASMS | prime motor cortex | blood oxygenation level dependent | BLOOD-FLOW | ADJACENT | HYPOXIA | IMAGE-GUIDED NEUROSURGERY | NEUROSCIENCES | NEUROIMAGING | relative regional cerebral blood volume | HIGH-RESOLUTION MEASUREMENT | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | functional magnetic resonance imaging | GRADIENT-ECHO | Image Enhancement | Humans | Middle Aged | Brain Neoplasms - physiopathology | Male | Statistics as Topic | Meningeal Neoplasms - blood supply | Hemangiopericytoma - blood supply | Brain Neoplasms - secondary | Neurons - physiology | Aged, 80 and over | Adult | Female | Neovascularization, Pathologic - physiopathology | Oligodendroglioma - blood supply | Astrocytoma - blood supply | Motor Cortex - blood supply | Magnetic Resonance Angiography | Blood Volume - physiology | Meningioma - blood supply | Oxygen - blood | Magnetic Resonance Imaging | Image Processing, Computer-Assisted | Aged | Regional Blood Flow - physiology | Glioblastoma - blood supply | Magnetic resonance imaging | Neurons | Gliomas | Brain tumors | Cancer | Brain | Nuclear magnetic resonance--NMR | Patients | Brain cancer | Surgery | Tumors
Journal Article